University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
983 Ergebnisse für "hans" unter University of Zurich
CV Hans-Joachim Voth
... CV Hans-Joachim Voth October 2019 HANS-JOACHIM VOTH University of Zurich +41-44 634 55 77 (PA) UBS ... ) European University Institute doctoral student (1993-94) 1 Curriculum Vitae - Hans-Joachim Voth Freiburg ... CV Hans-Joachim Voth ... CV Hans-Joachim Voth October 2019 HANS-JOACHIM VOTH University of Zurich +41-44 634 55 77 (PA) UBS ... CV Hans-Joachim Voth ...
UZH - Anthony Linden - Hans-Beat Bürgi
... Crystallography Prof. Hans-Beat Bürgi is a permanent academic guest at the Chemistry Department of the University ... UZH - Anthony Linden - Hans-Beat Bürgi ... UZH - Anthony Linden - Hans-Beat Bürgi Home Main navigation Search Jump to content Breadcrumb ... UZH - Anthony Linden - Hans-Beat Bürgi ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
18 Ergebnisse für "hans" unter Roche Glycart AG
Roche - Prof. Dr Hans Clevers
... Roche - Prof. Dr Hans Clevers ... Roche - Prof. Dr Hans Clevers We use cookies to give you the best online experience. By using our ... Roche - Prof. Dr Hans Clevers ...
Roche | Pharma Research and Early Development (pRED)
... breakthroughs every day. Found out some examples of areas where pRED is leading the field. Hans Clevers Head of ... discoveries in science are truly enabled when we have open minds and ears to share and collaborate. Hans ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1406 Ergebnisse für "hans" unter Somagenetix
UZH - Department of Biochemistry - Hans Rudolf Bosshard
... Publications Hans Rudolf Bosshard Hans Rudolf Bosshard studied Biochemistry at the Swiss Federal ... of Science. Hans Rudolf Bosshard's research focused on the molecular recognition between proteins ... UZH - Department of Biochemistry - Hans Rudolf Bosshard ... UZH - Department of Biochemistry - Hans Rudolf Bosshard Home Main navigation Search Jump to content ... UZH - Department of Biochemistry - Hans Rudolf Bosshard ...
UZH - Philosophisches Seminar - Hans-Johann Glock
... for Truth Research (VICTR) with contributions of Hans-Johann Glock, José Zalabardo and Juliet Floyd ... , Paul; Manser, Marta; Glock, Hans‐Johann (2022). Glock, Hans Johann (2021). Glock, Hans Johann (2021 ... UZH - Philosophisches Seminar - Hans-Johann Glock ... UZH - Philosophisches Seminar - Hans-Johann Glock Home Hauptnavigation Suche Direkt zum Inhalt ... UZH - Philosophisches Seminar - Hans-Johann Glock ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
344 Ergebnisse für "hans" unter ETH Entrepreneurship
Risk Day 2002, Prof. Hans-Jakob Lüthi, Prof. Paul Embrechts
... Risk Day 2002, Prof. Hans-Jakob Lüthi, Prof. Paul Embrechts Prof. Dr. Hans-Jakob Lüthi , Prof. Dr ... Risk Day 2002, Prof. Hans-Jakob Lüthi, Prof. Paul Embrechts ... Risk Day 2002, Prof. Hans-Jakob Lüthi, Prof. Paul Embrechts Prof. Dr. Hans-Jakob Lüthi , Prof. Dr ... Risk Day 2002, Prof. Hans-Jakob Lüthi, Prof. Paul Embrechts ...
Niklas Möhring wins Hans Vontobel Award for Agricultural Sciences 2...
... Niklas Möhring wins Hans Vontobel Award for Agricultural Sciences 2021 Niklas Möhring wins Hans ... Economic Analysis", Niklas Möhring has won the Hans Vontobel Prize for Agricultural Sciences 2021 ... Niklas Möhring wins Hans Vontobel Award for Agricultural Sciences 2021 – Department of ... https://usys.ethz.ch/en/news-events/news/archive/2021/05/Niklas-Moehring-gewinnt- hans-vontobel ... Niklas Möhring wins Hans Vontobel Award for Agricultural Sciences 2021 – Department of ...
Athebio AG
8952 Schlieren, Wagistrasse 18
+41 44 508 08 28
hello@athebio.com
Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug candidates.
Athebio AG
Wagistrasse 18
8952 Schlieren
2 Ergebnisse für "hans" unter Athebio AG
Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new membe...
... Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new member of the Board of Directors Dr ... . Hans-Peter Gerber Schlieren-Zurich, Switzerland, July 20, 2023 – At this year’s Annual General Assembly ... Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new member of the Board of Directors ... https://www.athebio.com/news/shareholders-of-athebio-ag-elect-dr- hans-peter-gerber-as-new-member-of ... Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new member of the Board of Directors ...
POINT Biopharma and Athebio Announce Partnership to Develop Designe...
... Press Release Next Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new member of the Board of ...
rqmicro AG
8952 Schlieren, Brandstrasse 24
+41 44 512 51 51
rqmicro’s separation and detection technology for microbiological tests in the water and food industry delivers reliable, quantitative and cost-effective results in less than 2 hours.
rqmicro AG
Brandstrasse 24
8952 Schlieren
14 Ergebnisse für "hans" unter rqmicro AG
rqmicro wurde eingeladen einen Vortrag an der Rapid Methods Europe ...
... . April 2015 Der Vortrag von Dr. Hans-Anton Keserue wird am Mittwoch, 22. April 2015 um 9 Ihr stattfinden ... Europe zu halten – 20-22. April 2015 Der Vortrag von Dr. Hans-Anton Keserue wird am Mittwoch, 22. April ...
rqmicro invited to speak at Rapid Methods Europe 20-22. of April 20...
... to speak at Rapid Methods Europe 20-22. of April 2015 The talk of Dr. Hans-Anton Keserue will be on ... speak at Rapid Methods Europe 20-22. of April 2015 The talk of Dr. Hans-Anton Keserue will be on ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
59 Ergebnisse für "hans" unter University Hospital Zurich, Research and Education Office
... trauma, orthopedics, and long bone reconstructions are: Hans-Christoph Pape (Chair; University Hospital ... Giannoudis (Leeds General Infirmary University Hospital, UK) Hans-Christoph Pape Prof. Dr. med., AO ...
Dinaqor
8952 Schlieren, Wagistrasse 25
DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.
Dinaqor
Wagistrasse 25
8952 Schlieren
9 Ergebnisse für "hans" unter Dinaqor
Board of Directors – DiNAQOR
... ventures Hans Rudolf Trüeb Lic. iur. and Dr. iur., Zurich University LL.M. Boalt Hall Law School, Berkeley ... of multiple biotech ventures Hans Rudolf Trüeb General Counsel & Corporate Secretary Lic. iur. and Dr ...
Management – DiNAQOR
... Executive roles at Merck, Aventis, Hoechst Hans Rudolf Trüeb LL.M. Boalt Hall Law School, Berkeley Adjoint ... in pharma and biotech Executive roles at Merck, Aventis, Hoechst Hans Rudolf Trüeb General Counsel ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
1 Ergebnisse für "hans" unter CSL Vifor
CSL Vifor Norway-EFPIA-09062023_Final.xlsx
... the contract Hans-Arne Myhre BODØ Norway Parkveien 95, 8005- BOD - - 26 000,00 kr 2 000,00 kr 28 ... the contract Hans-Arne Myhre BODØ Norway Parkveien 95, 8005- BOD - - 26 000,00 kr 2 000,00 kr 28 ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
23 Ergebnisse für "hans" unter Kuros Biosciences AG
Kuros Biosciences MagnetOs RCT FPI
... Advisors Michael Grau Hans Herklots Chief Financial Officer Investors t: +41 44 733 47 47 t: +41 79 598 ... Advisors Michael Grau Hans Herklots Chief Financial Officer Investors t: +41 44 733 47 47 t: +41 79 598 ...